Skip to main content
. 2022 Apr 30;3:13. doi: 10.21037/tbcr-22-21

Table 8. Recommendations of initial adjuvant therapy for triple negative breast cancer.

Stratification Level I recommendations Level II recommendations Level III recommendations
In the presence of any of the following conditions: positive lymph nodes; tumor sized >2 cm • AC→T 3 (1A) • TAC (1B) • FEC→T (2B)
• ddAC-ddT (1A) • TP (2A) • AC→TP (2B)
Patients at low risk of recurrence: tumor sized ≤2 cm and with negative lymph nodes • AC (1A) • AC→T (2A)
• TC ×4 (1A) • TC ×6 (2A)

T, taxene; A, anthracycline; C, cyclophosphamide; P, platinum; E, epirubicin; F, fluorouracil.